DDX3 was frequently downregulated in hepatitis B virus (HBV)-positive HCC samples, served as a favorable prognostic factor, and modulated the cell cycle progression and cell apoptosis via p21 (23). Here, DDX3X is linked to hepatocellular carcinoma.